Evaxion Biotech AS (EVAX)vsInsmed Inc (INSM)
EVAX
Evaxion Biotech AS
$4.00
+5.82%
HEALTHCARE · Cap: $31.53M
INSM
Insmed Inc
$136.00
-5.56%
HEALTHCARE · Cap: $31.17B
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 7956% more annual revenue ($606.42M vs $7.53M). EVAX leads profitability with a -102.4% profit margin vs -210.5%. INSM earns a higher WallStSmart Score of 39/100 (F).
EVAX
Avoid21
out of 100
Grade: F
INSM
Hold39
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Revenue surging 152.6% year-over-year
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -100.2% — below average capital efficiency
Revenue declined 100.0%
0.0% earnings growth
Trading at 39.4x book value
ROE of -249.3% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : EVAX
The strongest argument for EVAX centers on Price/Book.
Bull Case : INSM
The strongest argument for INSM centers on Revenue Growth. Revenue growth of 152.6% demonstrates continued momentum. PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bear Case : EVAX
The primary concerns for EVAX are EPS Growth, Market Cap, Return on Equity.
Bear Case : INSM
The primary concerns for INSM are EPS Growth, Price/Book, Return on Equity.
Key Dynamics to Monitor
EVAX profiles as a turnaround stock while INSM is a hypergrowth play — different risk/reward profiles.
INSM carries more volatility with a beta of 1.17 — expect wider price swings.
INSM is growing revenue faster at 152.6% — sustainability is the question.
EVAX generates stronger free cash flow (-7M), providing more financial flexibility.
Bottom Line
INSM scores higher overall (39/100 vs 21/100) and 152.6% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Evaxion Biotech AS
HEALTHCARE · BIOTECHNOLOGY · USA
Evaxion Biotech A / S, a clinical-stage artificial intelligence and immunology platform company, identifies and develops novel immunotherapies for the treatment of various cancers, bacterial diseases, and viral infections. The company is headquartered in Hoersholm, Denmark.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?